Patron Exim Limited IPO
i. Patron Exim Limited is engaged in the trading and distribution of wide range of pharmaceutical raw material which is also known as APIs (Active Pharmaceutical Ingredients), industrial chemical, excipient and solvents. Presently their product portfolio comprises of around 150 AIPs, Excipient, Pharma Chemical & Intermediates.
ii. They are also in the trading of variety of chemicals, such as, Petrochemicals, Dyes & Pigment Chemicals, Paints & Speciality Chemical, Agro Chemicals, Oil & Refinery Chemicals, Foam & Adhesive, Plywood & Laminates Chemical. The range of Chemicals also includes food industry & water treatment chemicals, resins & plastics chemicals, polymers and additives etc.
iii. In the FY 2022, the company had turnover of `387.95 lacs as against the turnover of `2053.58 lacs in FY 2021 and ` 2488.70 lacs in FY 2019. The Firm had switched to act as commission agent and charge the commission instead of purchasing the goods and selling the goods.
iv. APIs is known as bulk drugs or bulk actives are the principle ingredients used in making finished dosages in the form of capsules, tablets, liquid or other forms of dosage, with the addition of other APIs or inactive ingredients. The company believes that timely and committed delivery is an ongoing process of building and sustaining relationships. Their strength lies in understanding the requirements of the customer and our execution capabilities. This has enabled them to get repeated orders from their existing customers and attract new customers.
v. They are supplying raw materials to pharmaceutical industries and pharmaceutical industry falls under the essential business list declared by the Government. The company has continued its business operation during Covid -19 during lock down period. Their business was not affected during the Covid-19 period.
i. Diversified Product Portfolio
ii. Experienced Promoter
iii. Quality Service
Objects of the Patron Exim Limited IPO:
Patron Exim Limited IPO Details:
|Open Date:||Feb 21 2023|
|Close Date:||Feb 24 2023|
|Face Value:||₹ 10 Per Equity Share|
|Issue Type:||Fixed Price Issue IPO|
|Issue Size:||16.69 Cr.|
|Lot Size:||4000 Shares|
|Issue Price:||₹ 27 Per Equity Share|
|Listing At:||BSE SME|
|Listing Date:||Mar 06 2023|
Promoters And Management:
Financials of Patron Exim Limited IPO:
|Particulars ( In Lakhs )||8MFY23||2022||2021||2020|
|Revenue from Operations||960||387||2053||2488|
|Cost of Material Consumed||-||-||-||-|
|Purchase of Stock-in-Trade||1097||321||2127||2477|
|Changes in inventories||-255||15||-114||-26|
|Employee Benefits Expense||4||-||8||2|
|Depreciation & Amortisation||0.1||0.2||0.2||-|
Comparison With Peers:
|Name of the Company||Revenue (Cr)||Profit (Cr)||P/E||EPS||CMP||Mcap (Cr)|
|Patron Exim Limited||14||2||28.69||0.94||27||62|
|Vaishali Pharma Limited||68||6||24.8||6.03||149||157|
|Earum Pharmacuticals Limited||17||1||14.2||0.17||2.41||14|